Our results suggest that ALDH3A1 in glioblastoma is a target gene of the canonical Wnt signaling and we provide functional evidence that pharmacological inhibition of the pathway by porcupine inhibition increases susceptibly to TMZ treatment at least in part due to down-regulation of ALDH3A1. Here, ALDH3A1 is linked to glioblastoma.